Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis

Abstract excerpt

= 25). These findings raise the possibility of point-of-care diagnostic screening to identify patients at high risk of treatment failure and provide a rationale for a precision medicine approach to drug selection in cutaneous leishmaniasis. This work more broadly demonstrates the value of identifying genes of high variability in other diseases to better understand and predict diverse clinical outcomes.

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Research on Leishmaniasis Studies
• Share to Trypanosoma species research and implications